Mayzent Side Effects, RRMS, and its Safe Dosing Mayzent (by Novartis), the active substance of which is Siponimod, is an oral prescription medication approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Common Mayzent side effects observed in clinical trials […]